Literature DB >> 9778222

The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus.

H R Koene1, M Kleijer, A J Swaak, K E Sullivan, M Bijl, M A Petri, C G Kallenberg, D Roos, A E von dem Borne, M de Haas.   

Abstract

OBJECTIVE: To study whether the Fc gammaRIIIA-158V/F polymorphism, which affects IgG binding affinity, is a risk factor for systemic lupus erythematosus (SLE).
METHODS: We genotyped a group of 70 Caucasian SLE patients for all known Fc gammaR polymorphisms. Of this group, 45 patients (64%) had nephritis. In 35 patients, this diagnosis was confirmed by renal biopsy.
RESULTS: In the total group of 70 SLE patients, the frequency of the Fc gammaRIIIA-158F allele was 0.74, versus 0.57 in healthy controls (P = 0.003). The genotype distribution of the Fc gammaRIIIA-158V/F polymorphism was also significantly different from that of the control population (P = 0.004). The distribution of the other Fc gammaR polymorphisms--Fc gammaRIIA-131R/H, Fc gammaRIIIB-NA(1,2), and Fc gammaRIIIA-48L/R/H--was similar in SLE patients and controls.
CONCLUSION: In our group of SLE patients, only the distribution of the alleles of the Fc gammaRIIIA-158V/F polymorphism was significantly different from that in the control group. This might indicate that macrophage expression of the Fc gammaRIIIA-158F isoform is involved in the disturbed clearance of immune complexes in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778222     DOI: 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Genetics and systemic lupus erythematosus.

Authors:  B P Tsao; J M Grossman
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 3.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

4.  Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.

Authors:  Anne Baerenwaldt; Anja Lux; Heike Danzer; Bernd M Spriewald; Evelyn Ullrich; Gordon Heidkamp; Diana Dudziak; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

5.  Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease.

Authors:  Shoichiro Taniuchi; Midori Masuda; Masayuki Teraguchi; Yumiko Ikemoto; Yutaka Komiyama; Hakuo Takahashi; Minoru Kino; Yohnosuke Kobayashi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

6.  Distribution of the FcgammaRIIIa 176 F/V polymorphism amongst healthy Chinese, Malays and Asian Indians in Singapore.

Authors:  K T Chong; W F Ho; S H Koo; Peter Thompson; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

Review 7.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 8.  An update on genetic studies of systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 9.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

10.  Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.

Authors:  K Manger; R Repp; M Jansen; M Geisselbrecht; R Wassmuth; N A C Westerdaal; A Pfahlberg; B Manger; J R Kalden; J G J van de Winkel
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.